1. Home
  2. FULC vs SES Comparison

FULC vs SES Comparison

Compare FULC & SES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FULC
  • SES
  • Stock Information
  • Founded
  • FULC 2015
  • SES 2012
  • Country
  • FULC United States
  • SES United States
  • Employees
  • FULC N/A
  • SES N/A
  • Industry
  • FULC Biotechnology: Pharmaceutical Preparations
  • SES Auto Parts:O.E.M.
  • Sector
  • FULC Health Care
  • SES Consumer Discretionary
  • Exchange
  • FULC Nasdaq
  • SES Nasdaq
  • Market Cap
  • FULC 372.2M
  • SES 384.0M
  • IPO Year
  • FULC 2019
  • SES N/A
  • Fundamental
  • Price
  • FULC $6.40
  • SES $1.05
  • Analyst Decision
  • FULC Buy
  • SES Hold
  • Analyst Count
  • FULC 8
  • SES 3
  • Target Price
  • FULC $7.13
  • SES $1.50
  • AVG Volume (30 Days)
  • FULC 420.8K
  • SES 4.2M
  • Earning Date
  • FULC 07-29-2025
  • SES 10-30-2025
  • Dividend Yield
  • FULC N/A
  • SES N/A
  • EPS Growth
  • FULC N/A
  • SES N/A
  • EPS
  • FULC N/A
  • SES N/A
  • Revenue
  • FULC N/A
  • SES $11,360,000.00
  • Revenue This Year
  • FULC N/A
  • SES $883.92
  • Revenue Next Year
  • FULC N/A
  • SES $159.98
  • P/E Ratio
  • FULC N/A
  • SES N/A
  • Revenue Growth
  • FULC 2752.05
  • SES N/A
  • 52 Week Low
  • FULC $2.32
  • SES $0.20
  • 52 Week High
  • FULC $9.30
  • SES $2.53
  • Technical
  • Relative Strength Index (RSI)
  • FULC 44.51
  • SES 47.51
  • Support Level
  • FULC $6.36
  • SES $1.05
  • Resistance Level
  • FULC $6.75
  • SES $1.22
  • Average True Range (ATR)
  • FULC 0.30
  • SES 0.07
  • MACD
  • FULC 0.01
  • SES -0.01
  • Stochastic Oscillator
  • FULC 19.59
  • SES 31.82

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.

About SES SES AI Corporation

SES AI Corp is a developer and manufacturer of high-performance, AI-enhanced Lithium-Metal (Li-Metal) and Lithium-ion (Li-ion) rechargeable battery technologies for electric vehicles (EVs), Urban Air Mobility (UAM), drones, robotics, Battery Energy Storage Systems (BESS) and other applications. It includes Software and Hardware products that are EV, UAM, Drone, Molecular Universe, and Avatar.

Share on Social Networks: